Converting Enzyme Inhibition in Mild and Moderate Essential Hypertension. II |
| |
Authors: | STEN RASMUSSEN ARNE LETH HANS IBSEN META DAMKJR NIELSEN FINN NIELSEN J
RN GIESE |
| |
Institution: | STEN RASMUSSEN,ARNE LETH,HANS IBSEN,META DAMKJÆR NIELSEN,FINN NIELSEN,JØRN GIESE |
| |
Abstract: | ABSTRACT. In 24 patients with mild/moderate essential hypertension, we studied the effects of captopril with/without hydrochlorothiazide (Htz) on blood pressure, the renin-angiotensin system, blood bradykinin concentration (BBK), plasma volume, exchangeable sodium and glomerular filtration. Daily captopril doses of 75 and 150 mg were equally effective in reducing the blood pressure. Addition of Htz caused further blood pressure reductions. Nineteen patients attained a diastolic blood pressure ≤90 mmHg. Angiotensin converting enzyme inhibition with captopril led to a fall in plasma concentrations of angiotensin II (PAII) and renin substrate, and an increase in plasma concentrations of renin and angiotensin I. Patients starting with Htz had a higher PAII and subsequently a larger fall in blood pressure on captopril than untreated patients. BBK remained unchanged, indicating that the hypotensive action of captopril does not involve an accumulation of circulating kinin. Body fluid volumes and renal function were not affected by the various treatment regimens. |
| |
Keywords: | captopril mild and moderate essential hypertension maintenance treatment renin-angiotensin system blood bradykinin plasma volume exchangeable sodium renal function |
|
|